IDL Diagnostics attended the European Association of Urology (EAU) 2026 conference in London last week. We had valuable discussions with physicians who use our diagnostic biomarkers in clinical practice and research.
A big thank you to everyone we met at EAU26! We received many insightful inputs that will guide our ongoing development and help us stay focused on what matters most: delivering better, faster, and more accessible diagnostics for patients.
IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the position on May 28, immediately following the Annual General Meeting, succeeding Anders Hultman. Gustav Sten...
CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q1’26 results – May 13, 2026 Q1 Interview: Redeye talks with CEO Anders Hultman
On April 14, IDL participated at Redeye Healthcare Day. CEO Anders Hultman presented the company and shared more about its strategy, current and future markets, and our joint venture with concile. Watch the presentation here
